These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28783169)

  • 1. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.
    Guerrero PA; Tchaicha JH; Chen Z; Morales JE; McCarty N; Wang Q; Sulman EP; Fuller G; Lang FF; Rao G; McCarty JH
    Oncogene; 2017 Nov; 36(47):6568-6580. PubMed ID: 28783169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion.
    Reyes SB; Narayanan AS; Lee HS; Tchaicha JH; Aldape KD; Lang FF; Tolias KF; McCarty JH
    Mol Biol Cell; 2013 Feb; 24(4):474-82. PubMed ID: 23283986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma.
    Wu Q; Berglund AE; MacAulay RJ; Etame AB
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
    J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.
    Mao DD; Gujar AD; Mahlokozera T; Chen I; Pan Y; Luo J; Brost T; Thompson EA; Turski A; Leuthardt EC; Dunn GP; Chicoine MR; Rich KM; Dowling JL; Zipfel GJ; Dacey RG; Achilefu S; Tran DD; Yano H; Kim AH
    Cell Rep; 2015 Jun; 11(11):1809-21. PubMed ID: 26074073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNIPAAm-co-Jeffamine
    Heffernan JM; McNamara JB; Borwege S; Vernon BL; Sanai N; Mehta S; Sirianni RW
    Biomaterials; 2017 Oct; 143():149-158. PubMed ID: 28802102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of type I interferon on glioblastoma cancer stem cells.
    Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
    Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
    Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin.
    Tchaicha JH; Reyes SB; Shin J; Hossain MG; Lang FF; McCarty JH
    Cancer Res; 2011 Oct; 71(20):6371-81. PubMed ID: 21859829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.
    Tilghman J; Schiapparelli P; Lal B; Ying M; Quinones-Hinojosa A; Xia S; Laterra J
    Neoplasia; 2016 Mar; 18(3):185-98. PubMed ID: 26992919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
    Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
    Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
    Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH3BGRL2 functions as a crucial tumor suppressor in glioblastoma tumorigenesis.
    Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang C
    Biochem Biophys Res Commun; 2021 Apr; 547():148-154. PubMed ID: 33610914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic activity of SOX1 in glioblastoma.
    Garcia I; Aldaregia J; Marjanovic Vicentic J; Aldaz P; Moreno-Cugnon L; Torres-Bayona S; Carrasco-Garcia E; Garros-Regulez L; Egaña L; Rubio A; Pollard S; Stevanovic M; Sampron N; Matheu A
    Sci Rep; 2017 Apr; 7():46575. PubMed ID: 28425506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.